Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch

BenzingaAug 13 14:14 ET

Express News | Needham Initiates Coverage On Artiva Biotherapeutics With Buy Rating, Announces Price Target of $23

BenzingaAug 13 09:42 ET

A Quick Look at Today's Ratings for Artiva Biotherapeutics(ARTV.US), With a Forecast Between $18 to $23

Moomoo NewsAug 13 09:00 ET · Ratings

Express News | Artiva Biotherapeutics Inc : TD Cowen Initiates Coverage With Buy Rating

ReutersAug 13 06:44 ET

Artiva Biotherapeutics Analyst Ratings

BenzingaAug 13 06:39 ET · Ratings

Express News | Artiva Biotherapeutics Inc : Wedbush Initiates Coverage With Outperform Rating; Target Price $18

ReutersAug 13 06:34 ET